Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 18, 2019
Event: Unregistered Sales of Equity Securities (Item 3.02)
Key Financial Metrics
This filing reports a specific capital raise event rather than periodic financial performance metrics (e.g., revenue, profit, or cash flow).
- Funds Raised: $2.0 million
- Shares Issued: 1,369,863 shares of Class A common stock
- Price Per Share: $1.46
- Investor: MacAndrews & Forbes Group LLC
Material Changes
The Company exercised its right under a September 26, 2019 Letter Agreement to require the Investor to purchase the aforementioned shares. This transaction increased the Company's cash position by $2.0 million and diluted existing shareholders by the issuance of 1,369,863 new shares.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on operations, or specific risk factors beyond the standard disclosure that the transaction details are qualified by reference to the September 2019 Letter Agreement (Exhibit 10.1 to the Q3 2019 Form 10-Q).
Investor Verification Checklist
- Verify the terms of the September 26, 2019 Letter Agreement referenced in the filing.
- Confirm the total number of outstanding shares post-transaction to assess dilution impact.
- Review the Company's Q3 2019 Form 10-Q for the full text of Exhibit 10.1.
- Check subsequent filings for the utilization of the $2.0 million raised.